Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Serum TNF-a levels in rheumatoid arthritis patients treated with TNF inhibitors

  • At: 2012 FIP Congress in Amsterdam (the Netherlands)
  • Type: Poster
  • By: IWAKI-EGAWA, Sachiko (Hokkaido Pharmaceutical University, School of Pharmacy, Otaru, Japan)
  • Co-author(s): Hiura, K. (Department of Hospital Pharmacy, Obihiro Kosei General Hospital, Obihiro, Japan)
    Tachibana, E. (Hokkaido Pharmaceutical University, Otaru, Japan)
    Shibata, T. (Hokkaido Pharmaceutical University, Otaru, Japan)
    Satoh, K. (Hokkaido Pharmaceutical University, Otaru, Japan)
    Takeda, T. (Third Department of Internal Medicine, Obihiro Kosei General Hospital, Obihiro, Japan)
    Komori, H. (Department of Hospital Pharmacy, Obihiro Kosei General Hospital, Obihiro, Japan)
    Watanabe, Y. (Hokkaido Pharmaceutical University, Otaru, Japan)
  • Abstract:



    Background.


    Rheumatoid arthritis (RA) is an autoimmune disease characterized by a chronic inflammation. Tumor necrosis factor-a (TNF-a) is a cytokine and a key part of the autoimmune reaction. Many TNF-a antagonistic agents are now available in RA treatment and the use of them improved the prognosis of patients. Among them, etanercept (ETN)

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses